Stanniocalcin 2 induces oxaliplatin resistance in colorectal cancer cells by upregulating P-glycoprotein.

about

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma

P2860

Q58698791-0C68DC4C-679C-4841-BF5E-E1AABC7C64B9 Q58714240-0C347A2E-D11C-42A1-9836-8B674CB45D52

P2860

Stanniocalcin 2 induces oxaliplatin resistance in colorectal cancer cells by upregulating P-glycoprotein.

Item

http://www.wikidata.org/entity/Q38767306

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Stanniocalcin 2 induces oxalip ...... y upregulating P-glycoprotein.

@en

type

Item

label

Stanniocalcin 2 induces oxalip ...... y upregulating P-glycoprotein.

@en

prefLabel

Stanniocalcin 2 induces oxalip ...... y upregulating P-glycoprotein.

@en

P1476

Stanniocalcin 2 induces oxalip ...... y upregulating P-glycoprotein.

@en

P2093

Juan Liu

http://www.w3.org/2001/XMLSchema#string

Li-Li Zhang

http://www.w3.org/2001/XMLSchema#string

Lin Zhan

http://www.w3.org/2001/XMLSchema#string

Qiang Wang

http://www.w3.org/2001/XMLSchema#string

Qiong Yuan

http://www.w3.org/2001/XMLSchema#string

Xia-Min Hu

http://www.w3.org/2001/XMLSchema#string

Xin-Chu Yuan

http://www.w3.org/2001/XMLSchema#string

Zhen-Yu Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian stanniocalcins and cancer

Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression

Targeting multidrug resistance in cancer

The role of ATP binding cassette transporters in tissue defense and organ regeneration.

Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.

Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Identification of Ran-binding protein M as a stanniocalcin 2 interacting protein and implications for androgen receptor activity.

Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis.

Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.

P304

929-935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/CJPP-2015-0530

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27245421

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

Stanniocalcin 2 induces oxaliplatin resistance in colorectal cancer cells by upregulating P-glycoprotein.

about

P2860

P2860

Stanniocalcin 2 induces oxaliplatin resistance in colorectal cancer cells by upregulating P-glycoprotein.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921